What is the current Lower Limb Arterial Stents market size?

The Lower Limb Arterial Stents market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Lower Limb Arterial Stents market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Lower Limb Arterial Stents market?

Key drivers include rising prevalence of peripheral artery disease and advancements in stent technology.

What are the major challenges facing the Lower Limb Arterial Stents market?

Challenges include high costs, regulatory hurdles, and risk of complications, affecting future outlook.

Which regions are leading the Lower Limb Arterial Stents market?

North America and Europe are regional leaders, driven by strong healthcare infrastructure.

Who are the top companies in the Lower Limb Arterial Stents market?

Top companies include Medtronic, Boston Scientific, and Abbott, driving innovation and growth.

What future opportunities exist in the Lower Limb Arterial Stents market?

Emerging markets and advancements in bioabsorbable stents present significant future opportunities.

How is technology impacting the Lower Limb Arterial Stents market?

Advances in stent design, materials, and delivery systems are improving patient outcomes and market growth.

What is the current regulatory landscape for the Lower Limb Arterial Stents market?

The regulatory landscape is evolving, with increasing focus on safety, efficacy, and post-market surveillance.

Lower Limb Arterial Stents Value Chain Analysis & Forecast Outlook 2033

Lower Limb Arterial Stents by Application (Hospitals, Ambulatory Surgical Centers, Others), by Types (Balloon Expandable Stent, Self-Expandable Stents, Bare metal Stents, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Loading report content...

Loading report...

Lower Limb Arterial Stents Market Size | CAGR 7.8 Forecast 2033

Lower Limb Arterial Stents Value Chain Analysis & Forecast Outlook 2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.8%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Lower Limb Arterial Stents Market Overview

The Lower Limb Arterial Stents market refers to the industry involved in the development and distribution of stents used to treat arterial diseases in the lower limbs. As the Lower Limb Arterial Stents market size is expected to grow significantly, driven by an increasing prevalence of peripheral artery disease, the growth outlook and market forecast indicate a promising future for industry players. With a current market size of approximately $1.4 billion, the Lower Limb Arterial Stents market is poised for industry expansion, driven by advancements in stent technology, changing consumer behavior, and evolving regulations. The scope of this market encompasses various types of stents, including bare-metal stents, drug-eluting stents, and bioabsorbable stents, catering to diverse end-user needs.

Loading chart…

The Lower Limb Arterial Stents market is expected to grow at a CAGR of 7.5% from 2026 to 2033, driven by macro drivers such as an aging population, increasing healthcare expenditure, and advances in medical technology. Key forces shaping the industry include technology shifts, such as the development of bioabsorbable stents, regulations, such as those related to stent safety and efficacy, and consumer behavior, such as increasing awareness of peripheral artery disease. The largest region in the Lower Limb Arterial Stents market is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by industry expansion and increasing competitive intensity.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific Corporation; Abbott Vascular (Note: Abbott's vascular division); Medtronic; W.L. Gore & Associates; Becton, Dickinson and Company; Cook Medical; Cordis Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Lower Limb Arterial Stents market is poised for significant growth, driven by an increasing prevalence of peripheral artery disease and an expanding patient population. Understanding the dynamics driving this market is crucial for stakeholders seeking to capitalize on emerging opportunities.

Growth Drivers2 items

Advancements in stent technology, including the development of drug-eluting and bare-metal stents, are enhancing treatment outcomes and contributing to the growth of the Lower Limb Arterial Stents market size

Rising demand for minimally invasive procedures is fueling the adoption of Lower Limb Arterial Stents, with the global market expected to experience a substantial growth forecast in the coming years

Restraints2 items

Stringent regulatory requirements and high development costs are limiting the entry of new players in the Lower Limb Arterial Stents market, thereby restraining market growth

Complications associated with stent placement, such as in-stent restenosis and stent thrombosis, are concerns that may hinder the widespread adoption of Lower Limb Arterial Stents

Opportunities2 items

Emerging markets, particularly in Asia-Pacific and Latin America, present significant opportunities for growth due to their large and underserved patient populations, driving the Lower Limb Arterial Stents market size

The development of bioabsorbable stents is expected to revolutionize the Lower Limb Arterial Stents market, offering a promising solution for patients and paving the way for future growth

Challenges2 items

Intense competition among established players is a significant challenge in the Lower Limb Arterial Stents market, with companies competing on factors such as pricing, product features, and growth forecast

Maintaining profitability while complying with regulatory requirements and managing supply chain complexities is a key challenge for manufacturers in the Lower Limb Arterial Stents market

Market Segmentation

Loading chart…

The Lower Limb Arterial Stents market can be segmented based on application, which includes subtypes such as iliac artery stents, femoral artery stents, and popliteal artery stents. Each of these subtypes contributes to the overall Lower Limb Arterial Stents market size, with varying degrees of market share. Understanding the Lower Limb Arterial Stents segmentation is crucial for industry players to develop targeted strategies and capitalize on emerging opportunities.

In terms of types, the Lower Limb Arterial Stents market can be categorized into bare-metal stents, drug-eluting stents, and covered stents. These types of stents have distinct characteristics, advantages, and limitations, influencing their adoption rates and market growth. A thorough analysis of the market taxonomy is essential to comprehend the competitive landscape and identify areas for innovation and investment.

Lower Limb Arterial Stents Segmentation Breakdown9 items

Application

Hospitals

Ambulatory Surgical Centers

Others

Types

Balloon Expandable Stent

Self-Expandable Stents

Bare metal Stents

Others

Regional Insights

Loading chart…

The Lower Limb Arterial Stents market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: for North America, demographics with an aging population, ecosystem maturity with established healthcare systems, and infrastructure with advanced medical facilities. For Europe, drivers include policies supporting medical device innovation, adoption of minimally invasive procedures, and investments in research and development. In Asia Pacific, drivers comprise demographics with a large and growing population, infrastructure development with new healthcare facilities, and ecosystem maturity with increasing awareness of advanced medical treatments.

Latin America and Middle East & Africa are also expected to contribute to the Lower Limb Arterial Stents market growth, with key drivers including adoption of new medical technologies, policies supporting healthcare access, and investments in healthcare infrastructure. Understanding these regional dynamics is crucial for stakeholders to navigate the regional forecast and make informed decisions.

Competitive Landscape

The Lower Limb Arterial Stents market exhibits a moderately consolidated structure, driven by a mix of global players and local companies. The Lower Limb Arterial Stents competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies concentrate on regional expansion and cost advantages.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have distinct strategic focuses:

Boston Scientific Corporation: regional expansion

Abbott Vascular: innovation pipeline

Medtronic: premium pricing

W.L. Gore & Associates: local manufacturing

Becton, Dickinson and Company: OEM tie-ups

Cook Medical: vertical integration

Key Lower Limb Arterial Stents Companies7 items

Boston Scientific Corporation

Abbott Vascular (Note: Abbott's vascular division)

Medtronic

W.L. Gore & Associates

Becton, Dickinson and Company

Cook Medical

Cordis Corporation

Market Ecosystem

The Lower Limb Arterial Stents ecosystem spans multiple segments, from upstream technology providers and suppliers to midstream integrators and downstream channels, ultimately reaching end users. This complex network creates and captures value through the development, manufacturing, and distribution of stents, as well as related services and support. The ecosystem's boundaries are defined by the interactions among these participants, influencing how value flows through the system.

Raw material/component suppliers — provide materials for stent manufacturing

OEMs / manufacturers — design and produce Lower Limb Arterial Stents

Technology providers — develop underlying technologies for stent design and production

Distributors / channel partners — facilitate stent delivery to healthcare providers

Service providers / after-sales — offer maintenance, support, and training for stent use

End users / buyers — healthcare providers and institutions purchasing and using stents

Regulators/standards bodies — establish and enforce standards for stent safety and efficacy

In the Lower Limb Arterial Stents ecosystem, control points are primarily held by regulators and standards bodies, influencing adoption through approvals and compliance requirements. Dependency risks arise from input constraints, such as raw material availability, and standards, which can impact manufacturing and distribution. Switching costs and partnerships between participants can also affect the ecosystem's dynamics. Furthermore, regional differences in regulatory frameworks, healthcare systems, and market requirements can lead to variations in the ecosystem's structure and value chain analysis across different regions.

Recent Industry Insights

The Lower Limb Arterial Stents industry trends have witnessed significant developments over the last 12-18 months. Recently, there have been notable partnerships between key players, such as collaborations between stent manufacturers and medical research institutions, to enhance product innovation and clinical outcomes. Furthermore, the industry has seen strategic mergers and acquisitions, aimed at expanding product portfolios and strengthening market presence. Additionally, several product launches have taken place, introducing advanced stent technologies with improved efficacy and safety profiles. These developments underscore the dynamic nature of the Lower Limb Arterial Stents market, driven by ongoing research, technological advancements, and shifting consumer needs.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Lower Limb Arterial Stents market. The market attractiveness is moderate, driven by an increasing prevalence of peripheral artery disease and an aging population. The competitive intensity is high, with key players investing heavily in research and development. The long-term outlook for the Lower Limb Arterial Stents market outlook is promising, with advancements in technology and materials expected to drive growth.

The innovation landscape is evolving rapidly, with a focus on developing more effective and durable stents. However, the demand–supply balance is a key risk factor, as manufacturing constraints and regulatory hurdles may impact the availability of these devices. Overall, decision-makers should carefully consider these factors when navigating the Lower Limb Arterial Stents market.

12 items

1. Executive Summary

2. Lower Limb Arterial Stents Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Lower Limb Arterial Stents Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Lower Limb Arterial Stents Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Lower Limb Arterial Stents Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Lower Limb Arterial Stents Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Lower Limb Arterial Stents Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Lower Limb Arterial Stents Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Lower Limb Arterial Stents Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Lower Limb Arterial Stents Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Lower Limb Arterial Stents Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Lower Limb Arterial Stents Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Lower Limb Arterial Stents Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Lower Limb Arterial Stents Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Lower Limb Arterial Stents Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Lower Limb Arterial Stents Market Competition by Key Manufacturers

9.1. Global Lower Limb Arterial Stents Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Lower Limb Arterial Stents: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Boston Scientific Corporation

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Abbott Vascular (Note: Abbott's vascular division)

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Medtronic

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. W.L. Gore & Associates

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Becton, Dickinson and Company

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Cook Medical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Cordis Corporation

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Lower Limb Arterial Stents Market

Figure 4: Global Lower Limb Arterial Stents Market: Drivers

Figure 5: Global Lower Limb Arterial Stents Market: Challenges

Figure 6: Global Lower Limb Arterial Stents Market: Trends

Figure 7: Global Lower Limb Arterial Stents Market: Opportunity

Figure 8: Global Lower Limb Arterial Stents Market: Restraint

Figure 9: Global Lower Limb Arterial Stents Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Lower Limb Arterial Stents Market Value (USD Million) By Region

Figure 19: Global Lower Limb Arterial Stents Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Lower Limb Arterial Stents Market Value (USD Million) By Region

Figure 27: Global Lower Limb Arterial Stents Market Share (%) By: Regions (2032)

Figure 28: Global Lower Limb Arterial Stents Market Volume (K) By Region

Figure 29: Global Lower Limb Arterial Stents Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Lower Limb Arterial Stents Market Value (USD Million) By Region

Figure 37: Global Lower Limb Arterial Stents Market Share (%) By: Regions (2032)

Figure 38: Global Lower Limb Arterial Stents Market Volume (K) By Region

Figure 39: Global Lower Limb Arterial Stents Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Lower Limb Arterial Stents Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Lower Limb Arterial Stents Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Lower Limb Arterial Stents Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Lower Limb Arterial Stents Market Value (USD Million) By Region

Table 14: Global Lower Limb Arterial Stents Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Lower Limb Arterial Stents Market Volume (K) By Region

Table 31: Global Lower Limb Arterial Stents Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Lower Limb Arterial Stents Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Lower Limb Arterial Stents Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Lower Limb Arterial Stents Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Boston Scientific Corporation Basic Information And Sales Area

Table 52: Boston Scientific Corporation. Products Portfolio

Table 53: Abbott Vascular (Note: Abbott's vascular division) Basic Information And Sales Area

Table 54: Abbott Vascular (Note: Abbott's vascular division). Products Portfolio

Table 55: Medtronic Basic Information And Sales Area

Table 56: Medtronic. Products Portfolio

Table 57: W.L. Gore & Associates Basic Information And Sales Area

Table 58: W.L. Gore & Associates. Products Portfolio

Table 59: Becton, Dickinson and Company Basic Information And Sales Area

Table 60: Becton, Dickinson and Company. Products Portfolio

Table 61: Cook Medical Basic Information And Sales Area

Table 62: Cook Medical. Products Portfolio

Table 63: Cordis Corporation Basic Information And Sales Area

Table 64: Cordis Corporation. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Lower Limb Arterial Stents Market Value (USD Million) By Region

Table 74: Global Lower Limb Arterial Stents Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Application

Table 77: North America Market Value (USD Million) (2025-2032) By Types

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 90: Global Lower Limb Arterial Stents Market Volume (K) By Region

Table 91: Global Lower Limb Arterial Stents Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Lower Limb Arterial Stents Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.19 billion
Growth rate	CAGR of 7.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Boston Scientific Corporation; Abbott Vascular (Note: Abbott's vascular division); Medtronic; W.L. Gore & Associates; Becton, Dickinson and Company; Cook Medical; Cordis Corporation
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options